Holen Sie sich die Stockscreener-App
8.935
1.97%
-0.185
Schlusskurs vom Vortag:
$9.12
Offen:
$9.15
24-Stunden-Volumen:
187.89K
Relative Volume:
0.31
Marktkapitalisierung:
$362.86M
Einnahmen:
$324.01M
Nettoeinkommen (Verlust:
$-192.37M
KGV:
-1.8692
EPS:
-4.78
Netto-Cashflow:
$-23.46M
1W Leistung:
-2.08%
1M Leistung:
-8.59%
6M Leistung:
-28.25%
1J Leistung:
+16.71%
1-Tages-Spanne:
$8.91
$9.32
1-Wochen-Bereich:
$8.91
$9.35
52-Wochen-Spanne:
$5.83
$13.50
Angiodynamic Inc Stock (ANGO) Company Profile
Firmenname
Angiodynamic Inc
Sektor
Telefon
(518) 798-1215
Adresse
14 PLAZA DRIVE, LATHAM
Vergleichen Sie ANGO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ANGO
Angiodynamic Inc
|
8.93 | 374.64M | 324.01M | -192.37M | -23.46M | -4.78 |
|
ISRG
Intuitive Surgical Inc
|
498.88 | 177.75B | 9.15B | 2.61B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
182.16 | 53.11B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
91.38 | 45.44B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
276.52 | 40.35B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
252.36 | 18.95B | 2.90B | 467.20M | 306.90M | 6.37 |
Angiodynamic Inc Stock (ANGO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-16 | Eingeleitet | Lake Street | Buy |
| 2024-04-05 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2023-09-25 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-04-17 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2021-10-15 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2021-08-20 | Eingeleitet | Oppenheimer | Perform |
| 2020-11-25 | Hochstufung | Raymond James | Mkt Perform → Strong Buy |
| 2020-04-08 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-04-01 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2018-04-03 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2018-01-05 | Herabstufung | Craig Hallum | Buy → Hold |
| 2017-04-07 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2017-03-30 | Herabstufung | KeyBanc Capital Mkts | Overweight → Sector Weight |
| 2017-02-08 | Eingeleitet | Barclays | Equal Weight |
| 2016-11-04 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2016-04-08 | Fortgesetzt | Piper Jaffray | Neutral |
| 2016-01-08 | Bestätigt | Canaccord Genuity | Buy |
| 2015-11-10 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2015-07-24 | Eingeleitet | KeyBanc Capital Mkts | Overweight |
| 2014-06-19 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2012-10-09 | Bestätigt | Canaccord Genuity | Hold |
| 2012-06-25 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2011-07-15 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2011-07-15 | Hochstufung | Stifel Nicolaus | Hold → Buy |
| 2011-06-14 | Herabstufung | Wedbush | Neutral → Underperform |
| 2010-09-08 | Bestätigt | Wedbush | Neutral |
Alle ansehen
Angiodynamic Inc Aktie (ANGO) Neueste Nachrichten
What institutional investors are buying AngioDynamics Inc. stockMaximize your portfolio’s earning power - jammulinksnews.com
Is AngioDynamics Inc. stock overvalued or undervaluedPost Market Outlook For Every Investor - jammulinksnews.com
Building trade automation scripts for AngioDynamics Inc.Free Community Shared Smart Money Signals - Newser
How strong is AngioDynamics Inc. company’s balance sheetUnlock powerful investment tools for free - jammulinksnews.com
Is AngioDynamics Inc. a growth stock or a value stockUnprecedented profit potential - jammulinksnews.com
When is AngioDynamics Inc. stock expected to show significant growthMaximize returns with data-driven strategies - jammulinksnews.com
What is AngioDynamics Inc. company’s growth strategyOver 200% growth - jammulinksnews.com
How AngioDynamics Inc. stock performs during market volatilityFree High Yield Stocks With Buy Confirmation - Newser
Why AngioDynamics Inc. stock attracts strong analyst attentionEntry Level Low Risk Picks - Newser
New York State Common Retirement Fund Has $513,000 Stock Holdings in AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
What drives AngioDynamics Inc. stock priceUnstoppable profit momentum - PrintWeekIndia
Is AngioDynamics Inc. a good long term investmentOutstanding capital returns - PrintWeekIndia
What analysts say about AngioDynamics Inc. stockFree AI-Backed Trading Signals - Autocar Professional
AngioDynamics Inc. Stock Analysis and ForecastMarket-beating performance - Autocar Professional
Principal Financial Group Inc. Raises Stock Position in AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
AngioDynamics (NASDAQ:ANGO) Given a $17.00 Price Target at Canaccord Genuity Group - Defense World
HC Wainwright Reiterates Buy Rating for AngioDynamics (NASDAQ:ANGO) - Defense World
AngioDynamics Reports Strong Growth in Fiscal 2025 - The Globe and Mail
AngioDynamics, Inc. (NASDAQ:ANGO) EBITDA Improves - FXDailyReport.Com
AngioDynamics, Inc. (NASDAQ:ANGO) Q4 2025 Earnings Call Transcript - Insider Monkey
AngioDynamics Inc (ANGO) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid Tariff ... - Yahoo Finance
AngioDynamics Reports Strong Growth Amid Challenges - TipRanks
AngioDynamics, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:ANGO) - Seeking Alpha
AngioDynamics Inc reports results for the quarter ended May 31Earnings Summary - TradingView
Transcript : AngioDynamics, Inc., Q4 2025 Earnings Call, Jul 15, 2025 - MarketScreener
AngioDynamics Delivers Strong Q4 As Med Tech Sales Jump - Finimize
What makes AngioDynamics Inc. stock price move sharplyProfitable Yet Secure Picks - Newser
Finanzdaten der Angiodynamic Inc-Aktie (ANGO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.28%
0.60%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):